Pegaspargase

Category: Cancer



Pegaspargase Overview

Pegaspargase /pæsprez/, trade name Oncaspar, is a modified enzyme used as an antineoplastic agent. It is a form of L-asparaginase[1] which has undergone PEGylation. The drug is manufactured by Exelead, Inc. It is used in the treatment of acute lymphoblastic leukemia.[2][3] See also PEGylation References ^ "UNM Cancer Center". Archived from the original on September 3, 2006. Retrieved 2007-08-28..mw-parser-output cite.citation{font-s...

Read more Pegaspargase Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pegaspargase

Recent Pegaspargase Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Pegaspargase
  • Injection: 750IU/ml
  • Vial: 750iu/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Pegaspargase or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 17 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA